Home
How to arrive
Contact
Sitemap
CLICK HERE FOR AN ONLINE
PRE-DIAGNOSIS
AND A PERSONALIZED
COST ESTIMATE
WITH
NO OBLIGATION
THE CLINIC
FERTILITY TREATMENTS
SUCCESS RATES
QUALITY
Your fertility clinic in Barcelona (Spain)
Human Team
EUGIN Success Rates
Fertility treatments
Fertility and Infertility
FAQs
Scientific Publications
Facilities
EUGIN Art
EUGIN Foundation
Join our team
Artificial insemination
Conjugal Artificial Insemination (CAI)
Artificial insemination by donor (AID)
IVF: In Vitro Fertilization
IVF In vitro fertilization using eggs and sperm from the couple (Own IVF)
IVF In Vitro fertilization using eggs from a donor and sperm from the male partner
IVF In Vitro fertilization using eggs from the female partner and sperm from a donor
IVF In vitro fertilization using eggs from a donor and sperm from the sperm bank
ICSI
: In Vitro Fertilization with intracytoplasmic sperm microinjection
PGD
: Genetical diagnosis prior to implant
Scientific Publications
EUGIN Clinic
Racial disparity in oocyte donation outcome: a multiethnic, matched cohort study.
Bodri D, Guillén JJ, López M, Vernaeve V, Coll O.
Hum Reprod. 2010 Feb;25(2):436-42. Epub 2009 Nov 24.
Early ovarian hyperstimulation syndrome is completely prevented by gonadotropin releasing-hormone agonist triggering in high-risk oocyte donor cycles: a prospective, luteal-phase follow-up study.
Bodri D, Guillén JJ, Trullenque M, Schwenn K, Esteve C, Coll O.
Fertil Steril. 2009 Oct 1.
Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial.
Galindo A, Bodri D, Guillén JJ, Colodrón M, Vernaeve V, Coll O.
Gynecol Endocrinol. 2009 Jan;25(1):60-6.
Poor outcome in oocyte donation after elective transfer of a single cleavage-stage embryo in Turner syndrome patients.
Bodri D, Guillén JJ, Schwenn K, Casadesus S, Vidal R, Coll O.
Fertil Steril. 2009 Apr;91(4 Suppl):1489-92.
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study.
Bodri D, Guillén JJ, Galindo A, Mataró D, Pujol A, Coll O.
Fertil Steril. 2009 Feb;91(2):365-71.
Mitochondrial DNA depletion in oocytes of HIV-infected antiretroviral-treated infertile women.
López S, Coll O, Durban M, Hernàndez S, Vidal R, Suy A, Morén C, Casademont J, Cardellach F, Mataró D, Miró O, Garrabou G.
Antivir Ther. 2008;13(6):833-8.
Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles.
Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll O.
Reprod Biomed Online. 2008 Aug;17(2):237-43.
Fertility choices and management for HIV-positive women.
Coll O, Lopez M, Hernandez S.
Curr Opin HIV AIDS. 2008 Mar;3(2):186-92.
Le diagostic préimplantatoire (DPI) actuellement en Espagne.
Polo A, Vidal R, Bodri D, Coll O.
La lettre du Gynécologue 2008; 335:25-27 - Not indexed in PubMed
Prognostic factors in oocyte donation: an analysis through egg-sharing recipient pairs showing a discordant outcome.
Bodri D, Colodron M, Vidal R, Galindo A, Durban M, Coll O.
Fertil Steril. 2007 Dec;88(6):1548-53.
Endometrial receptivity after oocyte donation in recipients with a history of chemotherapy and/or radiotherapy.
Vernaeve V, Bodri D, Colodrón M, Vidal R, Durbán M, Coll O.
Hum Reprod. 2007 Nov;22(11):2863-7.
Fertility assessment in non-infertile HIV-infected women and their partners.
Coll O, López M, Vidal R, Figueras F, Suy A, Hernández S, Loncà M, Palacio M, Martínez E, Vernaeve V.
Reprod Biomed Online. 2007 Apr;14(4):488-94.
Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial.
Bodri D, Vernaeve V, Guillén JJ, Vidal R, Figueras F, Coll O.
Hum Reprod. 2006 Sep;21(9):2246-51.
How successful is repeat testicular sperm extraction in patients with azoospermia?
Vernaeve V, Verheyen G, Goossens A, Van Steirteghem A, Devroey P, Tournaye H.
Hum Reprod. 2006 Jun;21(6):1551-4.
Oocyte donation in patients with Turner's syndrome: a successful technique but with an accompanying high risk of hypertensive disorders during pregnancy.
Bodri D, Vernaeve V, Figueras F, Vidal R, Guillén JJ, Coll O.
Hum Reprod. 2006 Mar;21(3):829-32.
Decreased pregnancy rate after in-vitro fertilization in HIV-infected women receiving HAART.
Coll O, Suy A, Figueras F, Vernaeve V, Martínez E, Mataró D, Durban M, Lonca M, Vidal R, Gatell JM.
AIDS. 2006 Jan 2;20(1):121-3.
Eugin Research Chair
http://catedrarecercaeugin.uab.cat/articles.asp
The Clinic Eugin is a Health Centre authorized by the
Spanish Health Ministry
and by the Generalitat of Catalonia with file number P-7944 by which it is authorized to operate as a human assisted reproduction centre with the code number E08044858
EUGIN Clinic (Euvitro S. L. B-61663506) - C/ Entenza 293 and Travessera de les Corts 322
08029 Barcelona (Spain) - Telephone (00 34) 93 322 11 22 - Fax (00 34) 93 363 11 11 -
©2009 EUVITRO S.L.
Legal warning
- Security -
Privacy
-
Update:
2/26/2010
Information on the use of this website
Eugin, fertility clinic in Barcelona (Spain):
your personalized solution to fertility and infertility problems. Artificial Insemination, in vitro fertilization (IVF, ICSI, PGD), egg donation and sperm donation.
Clinic EUGIN
Fertility clinic
Fertility and Infertility
Fertility treatments
Artificial insemination
IVF - In vitro fertilization
ICSI
Your EUGIN solution
Egg donation